CA
OXFD

Cliff Asness’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Cliff Asness’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-22,184
Closed -$369K – 2211
2019
Q3 		$369K Buy
+22,184
New +$307K ﹤0.01% 1856

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $432M AUM 42.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Cliff Asness's OXFD Position: Q4 2019 in Review

Cliff Asness sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2019, closing a stake of 22,184 shares — an estimated $369K sold.

Cliff Asness first reported a position in OXFD in Q3 2019 and held it in 1 quarter. The position peaked at $369K in Q3 2019. 68 funds tracked by Wall St. Rank hold OXFD as of Q4 2019.

  • Cliff Asness reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2019 after selling out during the quarter.
  • Cliff Asness sold 22,184 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2019, an estimated $369K.
  • Cliff Asness first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2019 and held it in 1 quarter.
  • Cliff Asness's Oxford Immunotec Global PLC Ordinary Shares position peaked at $369K in Q3 2019.
  • 68 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2019.

Based on AQR Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.